Cargando…

Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assays

BACKGROUND: Despite considerable recent progress in the treatment of lung adenocarcinoma, there has been little progress in the development of efficacious molecular targeted therapies for squamous cell lung cancer. In addition to the recent comprehensive genome-wide characterization of squamous cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kenmotsu, Hirotsugu, Serizawa, Masakuni, Koh, Yasuhiro, Isaka, Mitsuhiro, Takahashi, Toshiaki, Taira, Tetsuhiko, Ono, Akira, Maniwa, Tomohiro, Takahashi, Shoji, Mori, Keita, Endo, Masahiro, Abe, Masato, Hayashi, Isamu, Nakajima, Takashi, Ohde, Yasuhisa, Yamamoto, Nobuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221703/ https://www.ncbi.nlm.nih.gov/pubmed/25348872 http://dx.doi.org/10.1186/1471-2407-14-786

Ejemplares similares

Frequency of EGFR T790M mutation and multimutational profiles of rebiopsy samples from non-small cell lung cancer developing acquired resistance to EGFR tyrosine kinase inhibitors in Japanese patients
por: Ko, Ryo, et al.
Publicado: (2016)

Prognostic significance of postoperative serum carcinoembryonic antigen levels in patients with completely resected pathological-stage I non-small cell lung cancer
por: Kozu, Yoshiki, et al.
Publicado: (2013)

Rebiopsy for patients with non‐small‐cell lung cancer after epidermal growth factor receptor‐tyrosine kinase inhibitor failure
por: Kawamura, Takahisa, et al.
Publicado: (2016)

Assessment of associations between clinical and immune microenvironmental factors and tumor mutation burden in resected nonsmall cell lung cancer by applying machine learning to whole‐slide images
por: Ono, Akira, et al.
Publicado: (2020)

Continuous paravertebral block using a thoracoscopic catheter-insertion technique for postoperative pain after thoracotomy: a retrospective case-control study
por: Yamauchi, Yoshikane, et al.
Publicado: (2017)

Prognostic impact of serum CYFRA 21–1 in patients with advanced lung adenocarcinoma: a retrospective study
por: Ono, Akira, et al.
Publicado: (2013)

Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy
por: Akamatsu, Hiroaki, et al.
Publicado: (2014)

Progression-free survival, post-progression survival, and tumor response as surrogate markers for overall survival in patients with extensive small cell lung cancer
por: Imai, Hisao, et al.
Publicado: (2015)

Characterization of tumour mutation burden in patients with non‐small cell lung cancer and interstitial lung disease
por: Kobayashi, Haruki, et al.
Publicado: (2019)

Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapy
por: Kasahara, Norimitsu, et al.
Publicado: (2015)

Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer
por: Imai, Hisao, et al.
Publicado: (2015)

Long-term survival after pulmonary resections for multiple metastases from gastric cancer: A case report
por: Kojima, Hideaki, et al.
Publicado: (2018)

Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter
por: Watanabe, Masaru, et al.
Publicado: (2018)

Aggressive adenocarcinoma of the lung consisting solely of discohesive cells
por: Kozu, Yoshiki, et al.
Publicado: (2013)

Proposing synchronous oligometastatic non–small‐cell lung cancer based on progression after first‐line systemic therapy
por: Miyawaki, Taichi, et al.
Publicado: (2020)

Primary malignant melanoma of the trachea: A case report
por: IMAI, HISAO, et al.
Publicado: (2015)

The effects of advanced age and serum α(1)‐acid glycoprotein on docetaxel unbound exposure and dose‐limiting toxicity in cancer patients
por: Kenmotsu, Hirotsugu, et al.
Publicado: (2017)

Osimertinib-induced interstitial lung disease after treatment with anti-PD1 antibody
por: Mamesaya, Nobuaki, et al.
Publicado: (2016)

Peroxisome proliferator-activated receptor γ agonist efatutazone impairs transforming growth factor β2-induced motility of epidermal growth factor receptor tyrosine kinase inhibitor-resistant lung cancer cells
por: Serizawa, Masakuni, et al.
Publicado: (2014)

Bronchial intraepithelial recurrence of a pulmonary large cell neuroendocrine carcinoma
por: Kojima, Hideaki, et al.
Publicado: (2020)

Comparison of platinum combination re-challenge therapy and docetaxel monotherapy in non-small cell lung cancer patients previously treated with platinum-based chemoradiotherapy
por: Imai, Hisao, et al.
Publicado: (2015)

Comparison of genetic susceptibility to lung adenocarcinoma and squamous cell carcinoma in Japanese patients using a novel panel for cancer-related drug-metabolizing enzyme genes
por: Ohnami, Sumiko, et al.
Publicado: (2022)

A favorable clinical effect of an expectorant in allergic bronchopulmonary mycosis caused by Schizophyllum commune
por: Kobayashi, Haruki, et al.
Publicado: (2016)

Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a prospective longitudinal observational study
por: Naito, Tateaki, et al.
Publicado: (2017)

Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non–small-cell lung cancer
por: Naito, Tateaki, et al.
Publicado: (2017)

Can (18)F-FDG PET predict the grade of malignancy in thymic epithelial tumors? An evaluation of only resected tumors
por: Nakagawa, Kazuo, et al.
Publicado: (2017)

Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab
por: Mamesaya, Nobuaki, et al.
Publicado: (2017)

A novel flow cytometry-based cell capture platform for the detection, capture and molecular characterization of rare tumor cells in blood
por: Watanabe, Masaru, et al.
Publicado: (2014)

Negative impact of malignant effusion on osimertinib treatment for non-small cell lung cancer harboring EGFR mutation
por: Kawamura, Takahisa, et al.
Publicado: (2019)

Pulmonary resection for metachronous metastatic gastric cancer diagnosed using multi-detector computed tomography: Report of five cases
por: Nishiwaki, Noriyuki, et al.
Publicado: (2020)

Adenosquamous carcinoma of the parotid gland
por: Kusafuka, Kimihide, et al.
Publicado: (2013)

Diagnostic sensitivity of solid volume measurement for pathological invasion in non-solid lung adenocarcinoma
por: Mizuno, Tetsuya, et al.
Publicado: (2023)

Acquired immunodeficiency associated with thymoma: a case report
por: Kawamura, Takahisa, et al.
Publicado: (2019)

Retrocardiac lung hernia after thoracic esophagectomy: report of a rare case
por: Furutani, Akinobu, et al.
Publicado: (2015)

Impact of Interstitial Lung Disease Classification on the Development of Acute Exacerbation of Interstitial Lung Disease and Prognosis in Patients with Stage III Non-Small-Cell Lung Cancer and Interstitial Lung Disease Treated With Chemoradiotherapy
por: Kobayashi, Haruki, et al.
Publicado: (2018)

Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities
por: Kobayashi, Haruki, et al.
Publicado: (2021)

Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic non-small cell lung cancer TRAP OLIGO study (WJOG11118L)
por: Miyawaki, Taichi, et al.
Publicado: (2021)

Adenosquamous carcinoma of the conjunctiva: A case report
por: KASE, SATORU, et al.
Publicado: (2014)

Association between oligo-residual disease and patterns of failure during EGFR-TKI treatment in EGFR-mutated non-small cell lung cancer: a retrospective study
por: Miyawaki, Taichi, et al.
Publicado: (2021)

Efficacy of prophylactic cranial irradiation in patients with limited-disease small-cell lung cancer who were confirmed to have no brain metastasis via magnetic resonance imaging after initial chemoradiotherapy
por: Mamesaya, Nobuaki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2uve0f0o9o3m9hbklmqmb4qbr3